|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 24 October 2006
doi: 10.1242/jcs.03263
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
Department of Biochemistry and Molecular Biology, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA
* Author for correspondence (e-mail: zouy{at}etsu.edu)
Accepted 15 September 2006
The genetic diseases Hutchinson-Gilford progeria syndrome (HGPS) and restrictive dermopathy (RD) arise from accumulation of farnesylated prelamin A because of defects in the lamin A maturation pathway. Both of these diseases exhibit symptoms that can be viewed as accelerated aging. The mechanism by which accumulation of farnesylated prelamin A leads to these accelerated aging phenotypes is not understood. Here we present evidence that in HGPS and RD fibroblasts, DNA damage checkpoints are persistently activated because of the compromise in genomic integrity. Inactivation of checkpoint kinases Ataxia-telangiectasia-mutated (ATM) and ATR (ATM- and Rad3-related) in these patient cells can partially overcome their early replication arrest. Treatment of patient cells with a protein farnesyltransferase inhibitor (FTI) did not result in reduction of DNA double-strand breaks and damage checkpoint signaling, although the treatment significantly reversed the aberrant shape of their nuclei. This suggests that DNA damage accumulation and aberrant nuclear morphology are independent phenotypes arising from prelamin A accumulation in these progeroid syndromes. Since DNA damage accumulation is an important contributor to the symptoms of HGPS, our results call into question the possibility of treatment of HGPS with FTIs alone.
Key words: DNA damage responses, Progeria, Lamin A, Farnesyltransferase inhibitor, DNA double-strand breaks, ATR and ATM checkpoints
Related articles in JCS:
This article has been cited by other articles:
![]() |
K. N. Dahl, A. J.S. Ribeiro, and J. Lammerding Nuclear Shape, Mechanics, and Mechanotransduction Circ. Res., June 6, 2008; 102(11): 1307 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dechat, K. Pfleghaar, K. Sengupta, T. Shimi, D. K. Shumaker, L. Solimando, and R. D. Goldman Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin Genes & Dev., April 1, 2008; 22(7): 832 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, Y. Wang, A. E. Rusinol, M. S. Sinensky, J. Liu, S. M. Shell, and Y. Zou Involvement of xeroderma pigmentosum group A (XPA) in progeria arising from defective maturation of prelamin A FASEB J, February 1, 2008; 22(2): 603 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Stewart, K. J. Roux, and B. Burke Blurring the Boundary: The Nuclear Envelope Extends Its Reach Science, November 30, 2007; 318(5855): 1408 - 1412. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Kieran, L. Gordon, and M. Kleinman New Approaches to Progeria Pediatrics, October 1, 2007; 120(4): 834 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Capell, F. S. Collins, and E. G. Nabel Mechanisms of Cardiovascular Disease in Accelerated Aging Syndromes Circ. Res., July 6, 2007; 101(1): 13 - 26. [Abstract] [Full Text] [PDF] |
||||